Načítá se...
Long-term response of over ten years with sorafenib monotherapy in metastatic renal cell carcinoma: a case report
BACKGROUND: Molecular targeted therapies have dramatically improved the prognosis of metastatic renal cell carcinoma. However, patients in whom the treatment could initially be effective will experience disease progression later. CASE PRESENTATION: A 74-year-old Japanese man who was diagnosed with r...
Uloženo v:
| Vydáno v: | J Med Case Rep |
|---|---|
| Hlavní autoři: | , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4911686/ https://ncbi.nlm.nih.gov/pubmed/27312478 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13256-016-0961-0 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|